MYCN and neuroblastoma: The collective data therefore indicate that RAMBAs encapsulated in liposomes have good bioavailability in neuroblastoma cells and are effective at augmenting ATRA signalling as evidenced by enhanced neurite elongation, AKT phosphorylation and N-myc suppression.